A 16mer peptide of the human autoantigen calreticulin is a most prominent HLA-DR4Dw4-associated self-peptide

Ziegler, 1981, Identification of a macrophage antigen processing event required for I-region restricted antigen presentation to T lymphocytes, J Immunol, 127, 1869, 10.4049/jimmunol.127.5.1869 Falk, 1991, Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules, Nature, 351, 290, 10.1038/351290a0 Rudensky, 1991, Sequence analysis of peptides bound to MHC class II molecules, Nature, 353, 622, 10.1038/353622a0 Chicz, 1992, Predominant naturally processed peptides bound to HLA-DR1 are derived from MHC-related molecules and are heterogenous in size, Nature, 358, 764, 10.1038/358764a0 Kropshofer, 1992, Self-peptide released from class II HLA-DR1 exhibits a hydrophobic two-residue-contact motif, J Exp Med, 175, 1799, 10.1084/jem.175.6.1799 Riberdy, 1992, HLA-DR molecules from an antigen-processing mutant cell line are associated with invariant chain peptides, Nature, 360, 474, 10.1038/360474a0 Newcomb, 1993, Characterization of endogenous peptides bound to purified HLA-DR molecules and their absence from invariant chain-associated αß dimers, J Immunol, 150, 499, 10.4049/jimmunol.150.2.499 Sette, 1992, Invariant chain peptides in most HLA-DR molecules of an antigen processing mutant, Science, 258, 1801, 10.1126/science.1465617 Chicz, 1993, Specificity and promiscuity among naturally processed peptides bound to HLA-DR alleles, J Exp Med, 178, 27, 10.1084/jem.178.1.27 Max, 1993, Characterization of peptides bound to extracellular and intracellular HLA-DR1 molecules, Hum Immunol, 38, 193, 10.1016/0198-8859(93)90540-H Kropshofer, 1993, Self-peptides from four HLA-DR alleles share hydrophobic anchor residues near the NH2-terminal including proline as a stop signal for trimming, J Immunol, 151, 4732, 10.4049/jimmunol.151.9.4732 Falk, 1994, Pool sequencing of natural HLA-DR, DQ and DP ligands reveals detailed peptide motifs, constraints of processing, and general rules, Immunogenetics, 39, 230, 10.1007/BF00188785 Hammer, 1993, Promiscuous and allele-specific anchors in HLA-DR-binding peptides, Cell, 74, 197, 10.1016/0092-8674(93)90306-B Sette, 1993, HLA DR4w4-binding motifs illustrate the biochemical basis of degeneracy and specificity in peptide-DR interactions, J Immunol, 151, 3163, 10.4049/jimmunol.151.6.3163 Michalak, 1992, Calreticulin, Biochem J, 285, 681, 10.1042/bj2850681 Sontheimer, 1993, Calreticulin: the diverse functional repertoire of a new human autoantigen, Immunologist, 1, 155 Klohe, 1988, Analysis of the molecular specificities of anti-class II monoclonal antibodies by using L cell transfectants expressing HLA class II molecules, J Immunol, 141, 2158, 10.4049/jimmunol.141.6.2158 Gorga, 1987, Purification and characterisation of class II histocompatibility antigens from a homozygous human B cell line, J Biol Chem, 262, 16,087, 10.1016/S0021-9258(18)47699-5 Kropshofer, 1991, Self and foreign peptides interact with intact and disassembled MHC class II antigen HLA-DR via Trp pockets, Biochemistry, 30, 9177, 10.1021/bi00102a008 Kropshofer, 1993, Evidence for co-binding of self- and allopeptides to human class II major histocompatibility complex antigen DR1 by energy transfer, 90, 403 Falk, 1990, Cellular peptide composition governed by major histocompatibility complex class I molecules, Nature, 348, 248, 10.1038/348248a0 Hill, 1991, Conformational and structural characteristics of peptide binding to HLA-DR molecules, J Immunol, 147, 189, 10.4049/jimmunol.147.1.189 Geluk, 1992, Functional analysis of DR17(DR3)-restricted mycobacterial T cell epitopes reveals DR17-binding motif and enables the design of allele-specific competitor peptides, J Immunol, 149, 2864, 10.4049/jimmunol.149.9.2864 Henderson, 1992, HLA-A2.1-associated peptides from a mutant cell line: a second pathway of antigen presentation, Science, 255, 1264, 10.1126/science.1546329